Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc > Takeover talks with Bausch Health?

<< Previous

Bullboard Posts

Next >>

Comment by Maxmoeon Jan 04, 2021 10:47pm

113 Views

Post# 32221532

RE:RE:RE:RE:Takeover talks with Bausch Health?

There are privates. Apparently apotex is not the only private drug co in Canada. It's so huge the tax losses probably don't matter and without Barry that company doesn't know what's up. But there are a few 10 to 50 million in sales private companies around

Majictrader wrote: Happy New Year Max and the Cipher gang. We need someone with a booty of $50-$60 million minimum for takeover assuming $2-2.50 price range. So Bausch, Gud...who else?

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals